Cel Sci Corporation (CVM)

[Biobonic]

Current state of affairs from a blighted perspective

Trial results effective, but determining who is eligible for just radiotherapy is traditionally determined after surgery. Multikine needs to be administered as soon as NHSCC is diagnosed.

Not only does BLA need to be written to back up the improvement, they need to definitely spell out a new procedure for determining who can receive Multikine prior to surgery.


Short position rose from 8.9 to 9.7 million in the last reporting period.

They are not quietly liquidating their position.

Shorts are a well heeled group with Stat 'News' in their corner, and $$ millions at their disposal.

CVM's defense has been tweets and a well meant website.

Shorts feed on fear. And there is plenty of opportunity for fear, as the FDA approval process is shrouded.

This story isn't over, not by a long shot.

Will the BLA get accepted? Will the new procedure be convincing, convincing enough for the FDA to say Yes?

Will Stat News keep to the facts? LOL

Link to Article

From my perch, currently on the sidelines